We previously reported that an envelope (Env) glycoprotein immunogen (o-gp140ΔV2SF162) containing a partial deletion in the second variable loop (V2) derived from the R5-tropic HIV-1 isolate SF162 partially protected vaccinated rhesus macaques against pathogenic SHIV SF162P4 virus. Extending our studies to subtype C isolate TV1, we have purified o-gp140ΔV2TV1 (subtype C ΔV2 trimer) to homogeneity, performed glycosylation analysis, and determined its ability to bind CD4, as well as a panel of well-characterized neutralizing monoclonal antibodies (mAb). In general, critical epitopes are preserved on the subtype C ΔV2 trimer; however, we did not observe significant binding for the b12 mAb. The molecular mass of subtype C ΔV2 trimer was found to be 450 kDa, and the hydrodynamic radius was found to be 10.87 nm. Our data suggest that subtype C ΔV2 trimer binds to CD4 with an affinity comparable to o-gp140ΔV2SF162 (subtype B ΔV2 trimer). Using isothermal titration calorimetric (ITC) analysis, we demonstrated that all three CD4 binding sites (CD4-BS) in both subtype C and B trimers are exposed and accessible. However, compared to subtype B trimer, the three CD4-BS in subtype C trimer have different affinities for CD4, suggesting a cooperativity of CD4 binding in subtype C trimer but not in subtype B trimer. Negative staining electron microscopy of the subtype C ΔV2 trimer has demonstrated that it is in fact a trimer. These results highlight the importance of studying subtype C Env, and also of developing appropriate subtype C-specific reagents that may be used for better immunological characterization of subtype C Env for developing an AIDS vaccine.
Introduction Acquired Immunodeficiency Syndrome (AIDS) continues to be a major health problem throughout the world, with approximately 40 million people infected with the human immunodeficiency virus type 1(HIV-1) and 20 million deaths due to AIDS to date. In the United States, an estimated one million individuals are currently living with HIV, and 40,000 to 80,000 new primary infections occur each year (UNAIDS/WHO, 2004) . The situation is continuously deteriorating as a result of the rapid emergence of drug resistance against most of the effective anti-virals. In certain parts of the world, such as Sub-Saharan Africa, India, and China, HIV-1 subtype C is the most prevalent strain. For instance, in Botswana and Swaziland, the prevalence of subtype C HIV infection is estimated to be as high as 35% (UNAIDS/WHO, 2004) . Therefore, there is an urgent need for an effective anti-HIV vaccine that can be used either alone as a prophylactic vaccine, or in conjunction with effective anti-virals as a therapeutic vaccine.
In the mid 1980s, during the early phase of the AIDS epidemic, induction of neutralizing antibodies (nAbs) was believed to be sufficient to protect against HIV infection. However, preclinical and early clinical trials in the early 1990s (Mascola et al., 1993 (Mascola et al., , 1996 confirmed that the neutralizing antibody responses induced by the monomeric HIV Env vaccines being tested at that time did not offer the breadth necessary to either prevent or control infection with naturally acquired field isolates of HIV. The focus then changed to the development of vaccines and regimens that would induce strong cellular responses. Early preclinical studies in rhesus macaques had established the correlation between strong cytotoxic T-cell (CTL) activity and reduced viral load. Subsequent studies using DNA prime/vector boost and vector prime/vector boost further strengthened the observation that strong cellular responses can serve as correlates of protection from disease development in animal models. However, recent data obtained in a rhesus macaque challenge model suggest that cellular responses that focus on a single epitope may not be sufficient to effectively control viral replication for extended periods of time due to the emergence of escape mutants Vogel et al., 2003) . It remains to be seen if increasing the breadth and potency of vaccine-elicited CTL responses will have a positive impact on the outcome of challenge infection. It is now widely believed that humoral, cellular, and T-helper cell responses, both at peripheral and mucosal sites, are needed to provide broad and durable protection against HIV. Conceptually, antibodies would serve as a first line of defense by either completely preventing infection or reducing the virus inoculums. Cellular responses would then facilitate the clearance of HIV-infected CD4+ T-cells that have escaped antibodymediated neutralization and reduce the severity of the disease. In a proof of concept study, Mascola et al. (2003) have shown that the induction of cellular responses using DNA vaccines in conjunction with passive transfer of nAbs did not exceed the protection afforded by passive transfer of nAbs alone. Further studies will be needed to demonstrate any potential advantage of inducing both potent cellular and humoral responses by an effective HIV vaccine.
The induction of broadly reactive nAbs against primary HIV-1 strains may prevent HIV infection by blocking the initial stage of infection (Graham, 2000) . Although it is difficult to elicit broadly nAbs against primary HIVor SIV strains in humans and in nonhuman primates (Johnston and Flores, 2001; Parren et al., 2001) , it has been shown that antibodies induced by prime-boost vaccine regimens can prevent immunodeficiency virus infection by inducing effective neutralizing antibody responses. For example, priming chimpanzees with replication-competent adenovirus-HIV gp160 recombinants, followed by boosting them with HIV-1 SF2 gp120 in MF59, elicited high serum titers of antibodies capable of neutralizing homologous and heterologous primary HIV-1 isolates in vitro. This finding correlated with in vivo protection of the animals against multiple, intravenous viral challenges Zolla-Pazner et al., 1998) . Furthermore, Mascola et al. (1999) and Ruprecht et al. (2001) have clearly demonstrated the positive effect of nAbs in passive immunizations upon the outcome of the challenge infection. Thus, the induction of broadly neutralizing antibody responses is important for developing an effective HIV vaccine.
The main question now is how to design immunogens that can induce nAbs of the right specificity and affinity to provide meaningful levels of protection against challenge with field isolates of HIV. We have pursued a modified-envelope HIV vaccine approach based on deleting the second hyper variable region (V2) from HIV envelope immunogens. This approach is based on several observations: (i) deletion of the V2 loop resulted in 100-fold increased susceptibility of antibody-mediated neutralization of mutant virus (Stamatatos and Cheng-Mayer, 1998a) ; (ii) deletion of the V2 loop alters the entry of mutant virus in CD4+ T-cells (Wyatt et al., 1995) ; (iii) CD4-inducible mAbs -such as 17b and 48d -better recognize V1/V2-deleted envelopes (Sullivan et al., 1998; Wyatt et al., 1995) ; and (iv) envelopes without V1 and V2 loops can mediate fusion with CCR5+ cells in the absence of the CD4 receptor (Johnson et al., 2002) . Taken together, these observations suggest that the V1 and V2 loops may mask conserved regions of the envelope involved in viral entry and susceptibility to neutralization (Johnson et al., 2002; Stamatatos and Cheng-Mayer, 1998b; Sullivan et al., 1998; Wei et al., 2003; Wyatt et al., 1995) . In addition, removal of the V1 and V2 loops may also eliminate several potential N-linked glycosylation sites (NLGS) and expose critical functional epitopes as recently described in the "glycan shield" model proposed by Wei et al. (2003) . Ly and Stamatatos (2000) have demonstrated that elimination of specific NLGS from the V2 loop renders the virus more susceptible to neutralization by various mAbs. Therefore, development of novel Env immunogens based on V2 loop deletion is relevant to developing an HIV vaccine. By introducing a partial deletion of the V2 loop in HIV Env immunogens derived from the R5-tropic, subtype B HIV strain SF162, we have altered the immunogenic properties of HIV Env as demonstrated by the immunogenicity studies in different animal models (Barnett et al., 2001; Srivastava et al., 2003) . Priming rhesus macaques with ΔV2SF162-envelope-encoding DNA vaccines, followed by boosting with o-gp140ΔV2SF162, confers partial protection against a pathogenic SHIVSF162P challenge (Barnett et al., 2001; Cherpelis et al., 2001a,b) . Quinnan et al. (2005) demonstrated that priming of rhesus macaques with alpha virus expressing R2 Env, followed by boosting with oligomeric protein, induced antibodies that neutralized diverse primary isolates. Furthermore, immunized rhesus macaques were protected against the challenge with partially pathogenic SHIV DH12R (Clone 7) as reflected by a reduction in the magnitude and duration of virus load.
In a more recent study, Quinnan and colleagues have clearly demonstrated that trimeric Env compared to monomeric Env is a potent immunogen (Zhang et al., 2007) . They have demonstrated that gp140R2 immunogen induced antibodies that achieved 50% neutralization of 48/48, and 80% neutralization of 43/46 primary strains of diverse HIV-1 subtypes tested. The strains tested included members of standard panels of subtype B and C strains, and other diverse strains known to be neutralization resistant. The gp120R2 induced antibodies neutralized only 9/48 of the same strains. Neutralization was IgG-mediated and HIV-1-specific.
Previously we reported on the engineering and characterization of soluble trimeric gp140 proteins derived from SF162 lacking the V2 loop (Srivastava et al., 2003) . Here, we describe the purification and characterization of V2 loop-deleted Env immunogen derived from TV1, an R5 dependent subtype C isolate derived from South Africa. We have previously shown that TV1 immunogens elicited homologous nAbs, and provided some breadth against a panel of heterologous subtype B and subtype C primary isolates (Lian et al., 2005) . EM studies indicate that the purified protein is in a stable trimeric conformation; immunochemical studies indicate that the subtype C ΔV2 trimer binds to CD4 at an affinity similar to subtype B ΔV2 trimers, and it has comparable glycosylation profile to subtype B ΔV2 trimer. However, there are differences between subtype B and C ΔV2 trimers in the binding profiles of mAbs. Our studies reveal differences in the presentation of neutralization epitopes on clade B and clade C gp140 immunogens that could affect the elicitation of neutralizing antibody responses.
Results and discussion

Results
Selection of subtype C HIV envelope
Several well-characterized subtype C isolates from South Africa (Estrelita Van Rensburg, Tygerberg Hospital, University of Stellenbosch) were evaluated for their sensitivity to neutralization by homologous and heterologous sera. The Env genes derived from proviral sequences from six clade C infected patients were amplified using primers derived from subtype C consensus sequence, and we cloned the PCR product in an expression vector. The insert was confirmed by restriction enzyme digest. The Env from six different clones was expressed, and characterized for level of expression in 293 and RD cells and its ability to bind to CD4. Only two clones expressed Env in 293 cells to a reasonable level, and the partially purified Env proteins bound to CD4 in an HPLC-based assay (data not shown). No detectable expression of any Env clone was observed in RD cells. Based on expression profile, CD4 binding, and fusogenicity (Lian et al., 2005) , TV1 was selected for further studies.
Analysis of leader sequences
To optimize the secretion of the expressed Env protein (gp120), three different leader sequences were evaluated transiently for the level of expression of secreted protein: (i) subtype C specific native leader sequence (Native), (ii) tissue plasminogen activator leader sequence (tPA), and (iii) an optimized version of the tPA sequence (tPAopt). Expressed Env proteins were partially purified, and analyzed by SDS-PAGE, and immunoprobing. The quantity of Env proteins secreted by these constructs was relatively similar (data not shown). Therefore, the construct with native leader sequence was chosen for further evaluation.
Expression and stabilization of o-gp140ΔV2TV1
To maximize the expression of gp140TV1ΔV2, the gene was modified. Consistent with our previous observations (Srivastava et al., 2003 (Srivastava et al., , 2002 zur Megede et al., 2000) , modified constructs expressed significantly higher levels of Env protein compared to un-optimized constructs (data not shown). We have previously shown that introduction of a single mutation (Arginine to Serine) in the protease cleavage site in HIV-1 Env gene from US4 (a subtype B primary isolate) was effective for stabilization of trimers (Srivastava et al., 2002) . However, the same R-to-S mutation was relatively ineffective for stabilization of trimers derived from SF162 (Srivastava et al., 2003) , and also for TV1 (Fig. 1) . Therefore, we evaluated several different combinations of mutations in the primary (aa494 to 497; REKR) and secondary (aa486 to 490; KAKRR) protease cleavage sites for their relative abilities to stabilize the TV1 Env trimer (Fig. 1) . Based upon expression profile, molecular mass and sCD4 binding, construct #7 which had a total of five mutations [two in the primary (E495-S, R497-S) and three in the secondary cleavages site (K488-I, R489-S and R490-S)] was the most effective at stabilizing the Env trimer. These mutations were used to derive stable CHO cell lines secreting o-gp140ΔV2TV1.
Selected clones were grown in presence of methotrexate at concentrations ranging from 50 nM to 800 nM, and maintained for a period of 3-4 weeks at one methotrexate concentration before moving on to the next drug concentration. Expression of Env was continuously monitored using a capture ELISA (Table 1) . Based on the expression profile at the highest methotrexate concentration, the three best clones were selected for further evaluation and adaptation in a 3.5 L perfusion bioreactor. Clone #24R was chosen as the cell line for the production of gp140ΔV2TV1, based on level of Env expression and growth characteristics of the cells.
Purification of o-gp140ΔV2TV1
A three-step strategy was used for efficient purification of o-gp140ΔV2TV1, involving a capture and two cleaning steps. The Env protein was efficiently captured over a GNA lectin column, while most contaminating proteins flowed through. The Fig. 1 . Structure and stabilization of HIV-1 subtype C Env in trimeric conformation. The linear map of gp120ΔV2 and gp41 of subtype C Env is presented. The gp120 variable regions (V1 to V5) are indicated as different shaded squares, and the protease cleavage site is marked with an arrow. All the protease cleavage site mutations (primary and secondary) that were evaluated for stabilizing subtype C trimers are shown. Effect of these mutations on the expression and stabilization of subtype C Env in trimeric conformation is also presented (T stands for trimer, and M for monomer). bound Env was eluted with 500 mM methyl mannose pyranoside (MMP). It was then passed over DEAE and CHAP columns, where contaminating proteins bound to the columns, but Env flowed through. The fractions collected from each column were analyzed by SDS-PAGE, immunoblot, size exclusion column chromatography (SEC), and a CD4 binding assay (Fig. 2) . The GNA lectin was very efficient at capturing the Env (N90%), but the purity was less than 50% ( Fig. 2A) . After the DEAE column, Env preparation was more than 60-70% pure, and the major contaminant was a serum protein (α-2 macroglobulin) ( Fig. 2A) . However after the final step, i.e. CHAP column, Env was more than 95% pure ( Fig. 2A) . The Env preparation was concentrated using a 100 kDa membrane, buffer was exchanged, and it was analyzed over SDS-PAGE (Fig. 2B) where purity was estimated to be N95% by densitometric scanning (data not shown). Furthermore, to determine the proportion of trimer, the purified preparation was analyzed over a BioSil 250 SEC (Fig. 2D ). Based on the SEC profile, the purified Env preparation consisted of approximately 70-80% oligomer and 20-30% monomer (Fig. 2D) . Therefore, at a final stage of purification, Env trimer was separated from monomer on a higher resolution, pre-calibrated Superdex-200 column with molecular weight standards of 670, 158, 44, 17, and 1.35 kDa (Fig. 3A) . We pooled different fractions constituting different parts of the peak to make five different pools. These pools were analyzed on PAGE under native ( Fig. 3B ) and reduced and denaturing conditions (Fig. 3C ). The data suggest that purified Env was in three different conformations: (i) larger structures representing the aggregated species N 670 kDa (pool 1); (ii) trimers N 440 kDa (pools 2, 3); and (iii) dimer b440 kDa (pool 4), and monomer N140 kDa (pool 5). However, all of these fractions migrated with an apparent molecular mass of 140 kDa on reducing and denaturing SDS-PAGE ( Fig. 3C ). No change in the electrophoretic mobility of these fractions was observed under denaturing conditions compared to reducing and denaturing conditions (data not shown) suggesting that Env monomers were noncovalently associated with each other to give rise to trimers. To further confirm that the purified Env is a genuine trimer, and not a disulfide-linked aggregate, the purified oligomers were treated with increasing concentrations of β-ME, and the samples were analyzed by HPLC using BioSil 250 column. No change in the mass of the Env protein was observed as reflected by the retention time upon treatment with increasing β-ME concentration suggesting that the trimers were not disulfide-linked aggregates (data not shown). Purified subtype C ΔV2 trimer was recognized as a single species on westerns blot using MAb 20-2-C8.5F3 directed against the conserved (C4) domain of subtype B gp120 ( Fig. 2C ) suggesting that there is no major degradation or proteolysis of o-gp140ΔV2TV1, and that the purified preparation was homogeneous.
Biochemical characterization of o-gp140ΔV2TV1
Glycosydic linkage analysis. The nature of the oligosaccharides linkages in the purified subtype C ΔV2 trimer was analyzed by digesting the Env protein with PNGF, which releases asparagine-linked oligosaccharides, with NANase II and O-glycosidase DS, which release unsubstituted Gal (β1, 3) GalNAc (α1) disaccharides attached to serine or threonine, either alone or in combination. Like o-gp140ΔV2SF162, subtype C ΔV2 trimer contained predominantly N-linked oligosaccharides since PNGF treatment appeared to remove all the sugars (Fig. 4A , lanes 3 and 6). Furthermore, we observed that NANase and O-glycosidase DS had no effect on electrophoretic mobility of subtype C ΔV2 trimer (Fig. 4A , lanes 4 and 5, respectively), similar to subtype B ΔV2 trimer (Srivastava et al., 2003) and also for o-gp140US4 (Srivastava et al., 2002) . Finally, digestion of subtype C ΔV2 trimer with a mixture of all three enzymes also had no discernible effect on the electrophoretic mobility compared to digestion with PNGF alone (Fig. 4A , lane 6). This is similar to what was previously reported by others and us for HIV Env proteins in monomeric and oligomeric conformation (Kozarsky et al., 1989; Srivastava et al., 2002) . Therefore, recombinant subtype C gp140ΔV2 trimers expressed in CHO cells contained few or no O-linked oligosaccharides, as was observed for both native (released from virions) and recombinant gp120 (Geyer et al., 1988; Mizuochi et al., 1988) and also for recombinant o-gp140 from US4 (Srivastava et al., 2002) . To ensure that purified Env was secreted from cells after passage through the endoplasmic reticulum and Golgi versus that released from the intracellular compartments by dead cells, Env was treated with Endo-H, which releases terminal mannose carbohydrates. After Endo-H digestion, a 15-20% reduction in the apparent molecular mass of subtype C ΔV2 trimer was observed ( Fig. 4B) , suggesting that not all high mannose sugars are exposed on the surface of the molecule, and carbohydrate modification of subtype C ΔV2 trimer has taken place in the Golgi network. This is in agreement with earlier data demonstrating that HIV Env protein has heterogeneous glycosylation.
Binding of subtype C ΔV2 trimer to CD4. The ability of native HIV Env to bind CD4 is essential for its biological function and can, therefore, serve as an indicator of native The kinetic analysis of subtype B and subtype C Env trimers binding to immobilized sCD4 was performed using SPR technique; binding sensograms (top part) along with residuals (bottom part) are presented in panels C (subtype C ΔV2 trimer) and D (subtype B ΔV2 trimer). Different sensograms in panels C and D were generated using a range of trimeric Env concentrations (37 to 250 nM). These data were prepared for kinetic analysis by subtracting binding responses collected from a blank reference surface. The association and dissociation phase data were fitted simultaneously to a single-site binding model by using Biaevaluation 3.2. The summary of the kinetic data for both subtype B and C ΔV2 trimers is presented in panel E.
structure and functionality of recombinant Env preparations (Scandella et al., 1993) . Using an HPLC-based receptor-binding assay (Srivastava et al., 2002) , subtype C ΔV2 Env was shown to bind to CD4 (Fig. 5B ) similar to the ΔV2 trimer derived from SF162 (Fig. 5A) . However, the retention time for subtype C ΔV2 trimer was shorter compared to subtype B ΔV2 trimer, suggesting that subtype C ΔV2 trimer is larger compared to subtype B ΔV2 trimer. The kinetic constants observed for ΔV2 trimers derived from TV1 and SF162 are presented in Figs. 5C-E. The calculated on rates for ΔV2TV1 and ΔV2SF162 trimers were 1.09E + 04 and 7.43E + 03, respectively. In addition, the dissociation rate for subtype C ΔV2 trimer was slightly slower compared to subtype B ΔV2 trimer. These data suggest tat ΔV2TV1 trimer has higher binding affinity to sCD4 than ΔV2SF162 trimer.
Isothermal titration calorimetric analysis. Since isothermal titration calorimetric (ITC) analysis is a very powerful technique not only for the strength of interaction, but also for determining the stoichiometry of receptor ligand binding, ITC was used to determine the stoichiometry of Env trimer and CD4. The data are presented in Fig. 6 . For the data analysis, it was assumed that if all the CD4 binding sites in the trimer were accessible, then the number of active sites (N) would be equal to 3, whereas for monomer the N would be equal to 1. The calculated numbers of CD4 binding sites for the trimer were found to be 2.79 and 0.965 for the trimer and monomer, respectively (Fig. 6C) , suggesting that N 90% of the Env molecules were functionally active in terms of their ability to bind CD4, and all three CD4 binding sites in the purified subtype C trimers are accessible. We have also calculated the affinity of each binding site in Env trimer for CD4. It was quite interesting to note that all three CD4 binding sites in the subtype C ΔV2 trimer had different KDs, suggesting cooperativity in binding (Fig. 6D ). This is in contrast to subtype B ΔV2 trimer, where all three CD4 binding sites had relatively similar KDs (Sharma et al., 2006) .
Immunochemical characterization of o-gp140ΔV2TV1
The structural integrity of subtype C Env was further evaluated by surface immunoprobing with a panel of mAbs of defined epitope specificities (IgGCD4, b12, 2F5, 4E10, 447D, 391-95d, G34, 17b, 4.8d 2.3E, LF17), using Surface Plasmon Resonance assay (SPR), capture ELISA, and Far Western assay. The mAb IgGCD4, which binds to the CD4-binding site, Fig. 6 . Thermodynamic properties of subtype C ΔV2 trimer were determined using isothermal calorimetric analysis (ITC). All titrations were performed in duplicate, and the heat of mixing and dilution was subtracted from the final data. Panel A represents the raw data depicting an endothermic reaction, where heat is consumed after each injection (power: time). The area under each spike is proportional to the heat consumed by each injection of Env into CD4. Panel B represents integrated areas per mole of injected ligand (envelope) as a function of molar ratio. For the trimeric Envs, the number of binding sites cannot be determined based on the values on X-axis. The solid line represents the best nonlinear fit to the experimental data. The kinetic data such as entropy (ΔS), enthalpy (ΔH), affinity of interaction (K), and calculated active sites in Env for CD4 (N) are presented in panel C. In panel D, the kinetic data for each binding site in Env for CD4 are presented.
recognized subtype B and C trimers confirming the earlier results obtained with CD4 (Fig. 7A) . The broadly reactive mAb, b12, whose epitope overlaps the CD4-binding site, efficiently recognized subtype B ΔV2 trimer, however, had negligible reactivity for subtype C ΔV2 trimer in capture ELISA (Fig. 7B) , as well as in SPR (data not shown). To determine the relative exposure of the V3 loop in the subtype C ΔV2 trimer compared to subtype B ΔV2 trimer, mAbs 447D and 391-95d were used. The mAb 391-95d recognized both subtype B and C ΔV2 trimers with similar efficiency, suggesting that the conformational epitope recognized by this mAb in V3 loop is well exposed in these trimers (Fig. 7C ). Similar observations were made for the mAb 447D (data not shown). As expected, both subtype B and C ΔV2 trimers were not recognized by a V2 loop specific antibody (Fig. 7D) . In the absence of sCD4, both subtype C and B ΔV2 trimers were recognized by mAbs directed to CD4-inducible epitopes. Upon binding to sCD4, both trimers underwent conformational changes as reflected by an increase in binding of the CD4 inducible specific mAbs 17b, 4.8d, 2.3E, and LF17. A typical example of binding of these trimers to mAb LF17 is presented in Fig. 8A . In general, the magnitude of binding of these mAbs to subtype C ΔV2 trimers was lower compared to subtype B ΔV2 trimer; however, the ability of subtype C ΔV2 trimers to undergo conformational changes in the presence of CD4 was similar to subtype B ΔV2 trimers (Fig. 8B) . The structural integrity of the purified subtype C ΔV2 trimer was further demonstrated by its ability to be recognized by a broadly neutralizing mAb 2F5 (Fig. 8C) . Comparative affinity of binding of subtype B and C ΔV2 trimers to 2F5 is presented in Fig. 8D . The 2F5 mAb recognizes a conserved neutralization epitope located in the ectodomain of the gp41 subunit. In addition, sera from HIV-1 infected individuals recognized both subtype B and C Env proteins, suggesting that immunodominant epitopes (other than the ones recognized by above-mentioned mAbs) are preserved and exposed similarly on these trimers (data not shown). Based on these observations, most of the critical neutralizing epitopes were intact and preserved on subtype C trimers.
Biophysical characterization of o-gp140ΔV2TV1
The subtype C Env protein was analyzed using triple detector analysis to estimate mass and hydrodynamic radius. The light scattering profile and hydrodynamic radius for subtype C Env are shown in Fig. 9A . The molecular mass of subtype C trimer was calculated to be 450 kDa, and the hydrodynamic radius was 10.7 nm. The light scattering profile suggested that the purified Env protein was predominantly homogeneous, with only a small proportion (b10-15%) in an aggregated state. The mass of the aggregates was estimated to be 868 kDa, nearly double the mass of trimer, suggesting that the aggregated state consisted of at least two or more trimers. Taken together, these data suggest that subtype C ΔV2 trimer was larger than the subtype B ΔV2 trimer (SF162), and had an increased ability to aggregate.
Negative stain EM
The biochemical data indicated that purified Env protein is predominantly in a trimeric conformation (Fig. 3A) . To further assess quaternary structure, negative stain electron microscopy analyses were carried out on different pools of Env protein. The representative fields from pool 3 are shown in Fig. 10A . The faster migrating molecules in pools 4 and 5 revealed images consistent with both monomeric and dimeric forms (data not shown), whereas molecules present in pool 3 appear to be primarily composed of three-lobed (trimeric) configurations (panel A and B). Unlike subtype B ΔV2trimers expressed in the same cells and purified the same way, it was quite remarkable to observe that ΔV2 trimers derived from subtype C were in two dominant conformations: (i) tight conformation with a smaller diameter (panel C), and the other (ii) extended conformation based on the position and size of the of the lobes (panel D). To illustrate the differences in the conformation of these molecules, we have also drawn side and top views of these molecules (panels E and F). It is possible that the observed variations in the conformational states of the molecule may also be due to different projections of the three-dimensional molecular volume of the trimer.
The dimensions of the subtype C Env molecules were in a range of 55-60 Å for the monomer, and 90-130 Å for the trimer. These data are consistent with previously reported measurements of the SOS gp140JR-FL construct (Schulke et al., 2002) . The trimers appear from the top as a triangular arrangement with a base of ∼130 Å and a depth of ∼ 90 Å. These dimensions are consistent with the putative arrangement of gp120 in a trimeric conformation (Chen et al., 2005) . The mass measurements estimated from the STEM micrographs (data not shown) indicated the presence of mono-disperse protein solutions, showing well-behaved Gaussian distributions corresponding to a mass of 113 kDa for the monomers and 353 kDa for the trimers (without the water molecules). A larger mass distribution was observed for the trimers (with a standard deviation of ∼8% of the mean for the trimers versus ∼5% for the monomer), which may be due to a smaller amount of aggregates or a lower proportion of heterogeneity in the carbohydrate moieties in the trimers.
Discussion
The HIV Env glycoprotein is the target of broadly crossreactive nAbs and will be an important component of a successful HIV vaccine. Therefore, it is important to engineer the most relevant Env protein conformation for inclusion in a potential HIV vaccine. It is well documented that gp120 monomer elicits high titer anti-env binding antibodies (Barnett et al., 1997; Haigwood et al., 1992; Mascola et al., 1999; Steimer and Haigwood, 1991) that neutralize T-cell adapted viruses, but are limited in their ability to neutralize primary isolates (Mascola et al., 1996; Moore et al., 1995; VanCott et al., 1995; Wrin and Nunberg, 1994) . Furthermore, the antibodies induced by gp120 react more strongly to monomer as compared to oligomer VanCott et al., 1995) . The observation that broadly reactive nAbs, such as IgG1b12, 2G12, and 2F5, generally have stronger affinity for the native envelope (trimer) than for monomeric gp120 or gp41 (Fouts et al., 1997; Roben et al., 1994) provides, at least conceptually, the impetus to evaluate trimeric Env glycoproteins as vaccine candidates Iyer et al., 2007; Pancera et al., 2005; Quinnan et al., 2005; Sanders et al., 2000 Sanders et al., , 2002 Srivastava et al., 2003 Srivastava et al., , 2002 Yang et al., 2000a Yang et al., ,b, 2002 Yang et al., , 2001 Zhang et al., 2007) . So far, the data support this approach, as oligomers have shown to be more effective in inducing strong antibody responses to conformational epitopes VanCott et al., 1995; Yang et al., 2001) . We have reported that a soluble oligomeric gp140 immunogen derived from the envelope of SF162 elicited cross-reactive nAbs in rabbits and macaques (Barnett et al., 2001 ). In addition, we have demonstrated that the animals immunized with o-gp140ΔV2 SF162 were partially protected after pathogenic challenge with SHIV SF162P4 (Barnett et al., 2001 ). Finally, we have also shown that, in intranasal prime and intramuscular boost regimen, subtype B trimeric Envbased vaccine induced strong antibodies that neutralized heterologous subtype B primary isolates (Srivastava et al., 2003; Vajdy et al., 2004) . In addition, Quinnan and colleagues induced potent antibodies that neutralized diverse primary isolates using an alpha prime and oligomeric protein boost strategy. Furthermore, immunized rhesus macaques were protected against the partially pathogenic SHIVDH12R (Clone 7) as reflected by the reduced magnitude and duration of viral load (Quinnan et al., 2005) . More recently, Zhang et al. compared the immunogenicity of oligomeric and monomeric Env in rabbits. They have clearly demonstrated that oligomeric Env is a better and more potent immunogen compared to monomer. Rabbits immunized with oligomeric Env induced antibodies that achieved 50% neutralization of 48/48, and 80% neutralization of 43/46 primary strains of diverse HIV-1 subtypes tested. The strains tested included members of standard panels of subtype B and C strains, and other diverse strains known to be neutralization resistant. However, the gp120R2 induced antibodies that neutralized 9/48 of the same strains (Zhang et al., 2007 ). These results demonstrate that induction of truly broad spectrum nAbs is an achievable goal in HIV-1 vaccine development. We have recently extended these studies on trimeric Env to subtype C, which is more prevalent in Sub-Saharan Africa and Asia. Based on various biochemical, immunological, and physical criteria, trimeric subtype C Env proteins were similar in most aspects to subtype B Env. In proof of concept immunogenicity studies in rabbits and monkeys, we have shown that ΔV2 trimers derived from TV1 induced antibodies that neutralized some heterologous isolates (Lian et al., 2005) and hence hold promise as vaccine candidates.
To elicit functional antibody responses, oligomeric HIV Env immunogens need to be stabilized to retain their trimeric conformation upon delivery. Several approaches are currently being used: (1) elimination of the protease cleavage site between gp120 and gp41 Earl et al., 1994 Earl et al., , 1991 Earl et al., , 2001 ; (2) introduction of intramolecular disulfide bond formation (SOS) between gp120 and gp41 Farzan et al., 1998; Sanders et al., 2000; Schulke et al., 2002) ; (3) in addition to the SOS modifications, introduction of an isoleucine-to-proline substitution at position 559 in the Nterminal heptad repeat region of gp41 (SOSIP) (Iyer et al., 2007; Sanders et al., 2002) ; (4) extension of the gp41 coiled coil region by the addition of GCN4 (a transcription factor that normally forms stable homotrimers) sequences, either alone or in conjunction with added cysteines between gp120 and gp41 (Farzan et al., 1998; Yang et al., 2000a,b) ; and (5) addition of a trimerization domain from the C terminus of bacteriophage T4 fibritin (Yang et al., 2002) . We have used the protease cleavage site mutation strategy to create stable trimers from subtype B (Srivastava et al., 2003 (Srivastava et al., , 2002 , and now from subtype C. Consistent with our previous work on SF162, we observed that several mutations in the primary and secondary cleavage sites are required for creating stable subtype C trimers. It appears that sequence variation, glycosylation, size of variable loops, expression levels, and the type of protein expression system may all play roles in stabilizing the HIV Env glycoprotein in oligomeric conformation (Yang et al., 2000a,b) . Therefore, optimal strategies for the generation of stable, soluble HIV envelope oligomers from a given isolate or clade will need to be determined experimentally on a case-by-case basis.
The binding of HIV Env protein to CD4, an obligatory step in viral replication (Dalgleish et al., 1984; Klatzmann et al., 1984) , is dependent upon conformation (Lasky et al., 1987; McDougal et al., 1986) and glycosylation (Barr et al., 1987; Li et al., 1993; Papandreou et al., 1996) . Evidence so far suggests that N-linked glycosylation is important for the formation of disulfide bonds which indirectly facilitate functional conformation and binding to CD4 (Fennie and Lasky, 1989; Fenouillet et al., 1989; Leonard et al., 1990; Li et al., 1993) . The V2 loop deletion that also involved the deletion of a glycosylation site at position 186 (Ly and Stamatatos, 2000; Maezawa et al., 1983) did not affect the ability of o-gp140ΔV2TV1 to bind to sCD4, suggesting that the purified protein was in its correct native conformation. The apparent affinity, kinetics, and thermodynamics of the CD4-Env interaction were studied by SPR and ITC. The dissociation constant (KD) for subtype C Env trimer was in nanomolar range and not significantly different from the KD of subtype B trimer (Sharma et al., 2006; Srivastava et al., 2003) . To determine if all three CD4 binding sites in a trimer are accessible for CD4 binding, we performed ITC analysis. Consistent with our previous data for subtype B (Sharma et al., 2006) , all three CD4 binding sites in subtype C trimer were accessible to CD4. However, what is unique about subtype C trimers is that the three CD4 binding sites have different affinities, suggesting a co-cooperativity for CD4 binding. Using gp120-GCN4 trimers, Pancera et al. (2005) have shown that only two out of the three CD4 binding sites were accessible in gp120 trimers, and the third binding site was exposed only upon deletion of variable loops 1 and 2. It is possible that access to all three binding sites may be dependent upon the orientation of the monomers, which is controlled by gp41. It appears that the folding of trimers created by a heterologous trimerization domain such as GCN4 (Pancera et al., 2005) is different from that of the trimers created by native gp41 sequence (Sharma et al., 2006; Srivastava et al., 2003) , as reflected by the accessibility of the CD4 binding sites. Our data generated using SPR, ITC, and mAb binding suggest that both subtype B and C Env proteins underwent significant molecular rearrangement upon binding to CD4. Similar findings were reported by Stites et al. (1997) . It is important to emphasize that thermodynamic parameters are highly dependent on the experimental conditions such as pH, temperature, buffer, etc.; therefore it is generally difficult to compare thermodynamic properties of similar molecules observed from different studies. Nevertheless, apparent affinities measured by SPR, as well as enthalpies and Gibbs free energies calculated from ITC data for subtype B and C trimers, were remarkably consistent with previous results. In those experiments, gp120 derived from a different isolate was produced in insect cells and was used under different experimental conditions. Myszka et al. (2000) reported that full-length gp120 expressed in Drosophila bound to CD4 with an affinity of 22 nM and an apparent Gibbs free energy of − 9.5 kcal/mol. Similar data were obtained for subtype B V2 loop-deleted trimers (Sharma et al., 2006) , and also for subtype C trimers(data not shown).
As mentioned previously, glycosylation of the Env is not directly involved in CD4 binding; however, it provides a functional conformation to facilitate CD4 binding. As a measure of proper glycosylation, we demonstrated that the purified subtype C Env trimers contained predominantly N-linked oligosaccharides, similar to monomeric and trimeric derived from other subtypes (Kozarsky et al., 1989; Srivastava et al., 2002) . Furthermore, we found that there are three kinds of polysaccharides associated with Env. We purified and sequenced two polysaccharides, and found that they were of terminal mannose and complex types. Similar observations were made of Env trimers derived from subtype B isolates such as US4 and SF162, and consistent to what is reported for native and recombinant Env proteins.
There is no consensus regarding the structure and the mass of recombinant HIV Env glycoproteins. Differences in the observed mass of putative trimers may be because they were derived from different isolates, produced under different conditions, and characterized by different techniques Earl et al., 1990 Earl et al., , 1991 Grundner et al., 2002; Schulke et al., 2002; Yang et al., 2000a Yang et al., , 2002 . In the present study, we performed an in-depth biophysical characterization of the purified subtype C protein by using triple detector analysis and negative stain EM. Combined, these methods strongly support the conclusion that the purified Env protein was predominantly in a trimeric conformation. As shown earlier, we found that the monomeric Env proteins had higher R h values of 5.07 nm for gp120 US4; and 4.33 nm for gp120SF162ΔV2 (Srivastava et al., 2003 (Srivastava et al., , 2002 . In contrast, Env glycoprotein trimers were tightly folded structures, as indicated by smaller than expected R h values: 8.4 nm for o-gp140US4 and 7.6 nm for subtype B ΔV2 trimer (Srivastava et al., 2003 (Srivastava et al., , 2002 , and 10.87 nm for subtype C trimer. It is quite surprising to observe that cleaved subtype A trimers produced using SOSIP approach have a size of 12-13 nm which is very similar to what we observed for uncleaved subtype C V2 loop-deleted trimers (Iyer et al., 2007) . These data are consistent with earlier observations that there are significant differences in the structure and folding of monomer and trimer Wyatt et al., 1998) . The reported molecular mass for transiently expressed Env protein oligomers derived from JR-FL, YU2, and HxBc2 is smaller than expected (400-410 kDa) Yang et al., 2000a) , and the molecular mass of the oligomer derived from JR-FL using SOSIP approach is considerably larger than expected (Grundner et al., 2002; Sanders et al., 2002) . More recently, Jeffs et al. (2004) have purified and characterized Env oligomers derived from different primary isolates, and it was quite puzzling to note that, with the exception of Env proteins derived from subtype F and O, all the other Envs derived from other subtypes (A, B, C, and D) were aggregated. Therefore, it is not trivial to purify Env proteins in correct structure and conformation.
To further evaluate subtype C Env structure, we performed deep-stain EM analysis and found the trimers to be in two basic conformations, which were characterized as open and closed. This is in contrast to our previous observations with subtype B Env, which appeared to be in a single, closed conformation (Srivastava et al., 2003) . It is possible that a more relaxed or open conformation, such as the one we observed for subtype C Env, may provide more access thereby inducing a broader spectrum of antibody responses.
We have determined the structural integrity of purified subtype C trimer using several mAbs of known epitope specificity such as those near or on the CD4-binding site (recognized by mAbs IgG1b12 and CD4-IgG2), the CD4-inducible site that overlaps the co-receptor binding site (recognized by mAb 17b and 4.8d, 2.3 E, LF17), gp41 (2F5), a carbohydrate-dependent epitope on gp120 (recognized by 2G12), and V3 loop epitopes (recognized by mAbs 447D and 391-95d). Interestingly, qualitative and quantitative differences were noted for subtype C versus subtype B Env (Srivastava et al., 2003) . Trimers derived from subtypes B and C bound to CD4 and mAb IgG-CD4; however, subtype C trimers showed no binding to b12 in capture ELISA assay and had 20-fold reduced binding to b12 by Biacore. Similarly, Jeffs et al. (2004) did not observe binding of subtype C Env to b12. Is it because the epitope recognized by b12 was not preserved on subtype C trimers, or because the b12 epitope is different on subtype C compared to subtype B? We have aligned the amino acid residues involved in b12 binding between subtype B and subtype C isolates, and observed that 5 out of 15 residues in subtype C are different compared to subtype B. If the difference in b12 binding between subtype B and C trimeric V2 Env can be attributed to this difference, remains to be determined. It has been observed by David Montefiori (personal communication) and Julie Overbaugh (personal communication) that the concentration of b12 required to neutralize TV1 virus is at least a log higher than that required for SF162 virus. These data are consistent to the fact that b12 epitope is not completely preserved in subtype C isolate compared to subtype B. In general, the magnitude of binding of mAbs directed against the CD4i epitopes was lower for subtype C trimer compared to subtype B trimer either in the presence or absence of CD4. However, the fold increase in the mAbs directed against CD4-inducible epitopes observed in presence of CD4 was similar for subtype B and C trimers, suggesting that subtype C trimer also underwent structural rearrangement. The other broadly neutralizing epitopes such as those recognized by mAbs 2F5 and 4E10 were exposed and preserved in subtype C Env trimers. However, these epitopes appear to have been lost or not preserved in Env derived from another subtype C isolate BA29 (Jeffs et al., 2004) . Whether this was due to differences between the TV1 and BA29 strains or due to aggregation of the BA29 Env preparation remains to be determined.
Taken together, the data demonstrate that a V2-deleted form of Env trimer derived from the TV1 subtype C strain can be produced in -and purified from -CHO cells. The resulting preparation is predominantly trimer with many similar biophysical, biochemical, and immunological characteristics to subtype B Env protein.
Furthermore, it has induced nAb responses in rabbits, consistent with our previously reported immunogenicity studies in rabbits and rhesus macaques (Lian et al., 2005) . These data emphasize the potential role of trimeric Envs for vaccine applications.
Materials and methods
Cloning full length or V2-modified subtype C HIV envelope variants
The sequences encoding the open reading frame of the ectodomain of the Env protein from the HIV-1 TV1ΔV2 isolates were codon-modified as described elsewhere (Haas et al., 1996; zur Megede et al., 2000) , and constructed synthetically as a 2.1 kb EcoRI-XbaI DNA fragment. In order to stabilize the oligomeric structure of the encoded gp140 protein, we introduced a series of mutations in the primary (REKR) and secondary protease (KAKRR) cleavage sites in the Env polypeptide (Earl and Moss, 1993) . The details of these mutations are presented in Fig. 1 . The synthetic PCR products were digested with EcoRI/XhoI and cloned into the pCMVIII vector for protein production. The pCMVIII vector contains the CMV immediate early enhancer and promoter, a polylinker for multiple cloning sites, a bovine growth hormone polyA termination signal, a kanamycin resistance gene, and an E. coli origin of replication. In addition, it contains Mdhfr (Dihydrofolate reductase) and Neomycin resistance genes that allow for stable transfection, selection and amplification of the gene of interest in Chinese Hamster Ovary (CHO) cells. Similar methods were used to clone a consensus envelope gene (E0975) derived from published subtype C sequences from Botswana.
Transient transfection
Plasmids encoding the various gp140 forms of the TV1 env were transiently transfected into 293T cells, and gp140 protein expression was quantitated 48 to 72 hour post-transfection in cell lysates and in supernatants. The supernatants were used for partial purification of the Env protein from different clones. These semi-purified subtype C Envs were screened for their ability to bind CD4, and to determine levels of expression by SDS-PAGE analysis and quantitative immunoprobing.
Development of stable CHO cell lines secreting o-gp140ΔV2TV1
Stable CHO cell lines secreting gp140ΔV2TV1 were derived using DG-44 cells that have a double deletion mutation in the DHFR gene, thus making the cell line dependent on the addition of hypoxanthine, glycine, and thymidine to the growth media, following the experimental protocol described elsewhere (Srivastava et al., 2002) .
Production of o-gp140ΔV2TV1
The three highest expressing gp140ΔV2TV1-CHO cell clones were used to seed 3 L bioreactors (one for each clone) for adaptation to low serum containing media (0.5%) and cell density and perfusion rate that facilitated the maximum expression of gp140ΔV2TV1. Bioreactors were monitored daily for cell density, pH, dCO 2 , dO 2 , glucose, lactate, glutamine, and ammonia concentrations. The structure, conformation, and expression levels of secreted gp140ΔV2TV1 were monitored weekly. From the three bioreactor-adapted clones, the best producer clone was used to seed a 12.5 L bioreactor for production run. At the end of the run, collected media was concentrated 20-fold through a 100-kDa-membrane filter and stored at − 80°C in presence of 1 mM EDTA and 1 mM EGTA.
Purification of o-gp140ΔV2TV1
The o-gp140ΔV2TV1 was purified from the concentrated CHO cell supernatant using a lectin capture, and two ion exchange steps as described elsewhere in detail (Srivastava et al., 2003 (Srivastava et al., , 2002 . All the column fractions were analyzed on polyacrylamide gels (PAGE; native, and reduced and denatured conditions) and also in a CD4 receptor-binding assay (see below). The fractions showing strong CD4 binding activity were pooled and fractionated on a 16 × 90 mm Superdex-200column (Pharmacia, Sweden) equilibrated with 10 mM NaCitrate containing 300 mM NaCl. Fractions containing o-gp140ΔV2 were pooled, concentrated using a Stir cell (Millipore, Inc., Bedford, MA), and stored frozen at − 80°C. During the purification process, fractions were analyzed by PAGE both under reducing and denaturing and under native conditions following standard methods. Gels were stained with Coomassie brilliant blue or processed for immunoblotting.
Biophysical characterization of o-gp140ΔV2TV1
The molecular mass (Mw), hydrodynamic radius (R h ), and intrinsic viscosity (IV) of o-gp140ΔV2TV1 were determined using a triple detector array system (TDA 300, Viscotek Corp., Houston, TX) in conjunction with a pre-calibrated gel filtration HPLC column (Bio Sil SEC-250; BioRad Laboratories, Hercules, CA) using Alliance 2690 HPLC system (Waters Corporation, Milford, MA). Approximately 100 μg of the purified protein (gp140ΔV2TV1) was analyzed in 20 mM NaH 2 PO 4 , 2 mM Na 2 HPO 4 buffer at pH 7.4 at the flow rate of 1 ml/min. The signals from light scattering, viscometer, and refractive index detectors were collected and analyzed using EZ Pro software package (Viscotek Corp., Houston, TX).
CD4 binding assay
To determine the capability of purified envelope protein to bind CD4, we used an HPLC-based assay using fluorescinated CD4 as described elsewhere in detail (Srivastava et al., 2002) . Purified sCD4 was labeled with amine-reactive succinimidyl esters of carboxyfluorescein following the instructions provided by manufacturer (Molecular Probes, Inc., Eugene, OR). Approximately 1 μg of purified HIV Env protein gp120 was mixed with 0.33 μg of fluorescinated-CD4 (equal molar concentrations) in a reaction volume of 60 μl using 2× phosphate-buffered saline at pH 7.4. After a 15 min incubation at the RT, 50 μl of this sample was injected onto a Bio Sil SEC-250 (Bio-Rad laboratories, Hercules, CA) gel filtration high performance liquid chromatography (HPLC) column using Alliance 2690 HPLC system (Waters Corporation, Milford, MA). Samples were run in 20 mM NaH 2 PO 4 , 2 mM Na 2 HPO 4 ,and 400 mM ammonium sulfate buffer, pH 6.0, at the flow rate of 1 ml/min. The fluorescence profile was monitored at 490 nm using a 996 fluorescent detector and Millennium software package (Waters Corporation, Milford, MA).
Glycosylation profile analysis
The glycosylation profile of the purified proteins was assessed by four methods as described elsewhere in detail (Srivastava et al., 2002) : first, enzymatic deglycosylation of the purified HIV-Env proteins was performed using reagents from BioRad Research Laboratories, Hercules, CA (catalog # 170-6500). Briefly, to detect N-linked and O-linked oligosaccharides, 25-100 μg of the purified protein was treated separately with Peptidyl N-glycosidase F (PNGF) (2.5 U/ml; at 37°C for 1 h); and NANase II and O-glycosidase (1 U/ml; at 37°C for 1 h). At the end of the incubation period, samples were diluted in sample buffer containing 0.1% SDS and β-mercaptoethanol and analyzed by SDS-PAGE. In addition, we have also performed Endo-H digestion of the purified protein following manufacturer's protocol (Boehringer Mannheim).
Immunochemical characterization of o-gp140ΔV2TV1
The binding of well-characterized HIV-Env specific mAbs, all derived from clade B HIV-1-infected patients, was performed by a capture ELISA. Subtype C ΔV2 trimers were captured by its gp41 portion via the mAb D50 that recognizes a linear gp41 peptide (Earl et al., 1997) as described previously (Stamatatos and Cheng-Mayer, 1995) . Briefly, ELISA plates were coated with these respective antibodies at a concentration of 10 μg/ml and o-gp140ΔV2 from subtypes B and C was captured. The captured proteins were incubated with serial dilutions of various mAbs (0.01 mg/ml to 10 mg/ml) for 2 hour at RT. Plates were washed, and specifically bound antibodies were detected using anti-mouse IgG coupled to alkaline phosphatase as described earlier (Srivastava et al., 2003 (Srivastava et al., , 2002 .
Surface plasmon resonance assay
Surface Plasmon Resonance assays were performed using a BIACORE 3000 optical biosensor system (Biacore AB, Uppsala, Sweden) with simultaneous monitoring of relevant flow cells. To perform the kinetic study of the binding of subtype C ΔV2 trimer and subtype B ΔV2 trimer to sCD4, sCD4 was immobilized using carbodiimide coupling onto a low charge CM3 sensor chip to attain a response of 2000 RU. Using PBS (pH 7.4) with 0.05% Tween 20, association was assessed by passing subtype C ΔV2 trimer and subtype B ΔV2 trimer over the CD4 in different flow cells at a flow rate of 20-30 μl/min. The concentration range for subtype C ΔV2 trimer and subtype B ΔV2 trimer was 15 to 500 mM. We have used Bovine Serum Albumin (BSA) as negative control. For kinetic analysis, Biosensor data were prepared by subtracting binding responses obtained for BSA from the specific responses. The association and dissociation phase data were fitted simultaneously to a single-site binding model by using the nonlinear data analysis software BIAevaluation 3.2.
mAbs binding assay
To perform the binding of HIV Env to different mAbs such as b12, 2F5, 4E10, 2G12, 17b, 48d, 23E, and LF17, these antibodies were immobilized on to CM5 sensor chip using amine coupling reaction to attain approximately 1000 RUs, and the assay was performed under the experimental conditions described as above.
Isothermal titration calorimetric (ITC) analysis
Isothermal titration calorimetry was performed on a VP-ITC (Microcal LLC, Northampton, MA) using a 1.4 ml cell, and a 0.25 ml syringe. Proteins were dialyzed extensively in PBS containing 0.005% Tween and concentrated using a stir cell (Millipore Inc.) prior to loading. Three to five millimolar CD4 was loaded in the cell, with 18 to 30 mM envelope protein in the syringe. Titrations were performed using 15 μl injections with a 5 min delay between each injection. All runs were adjusted for heat of dilution and mixing by subtracting a blank run of envelope titrated into buffer only. Binding isotherms obtained were auto-fitted for a floating number of binding sites using Origin® software (MicroCal LLC, Northampton, MA). Fits were generated using the Origin® 7.0 software parameter "ligand in cell" option; thus, generated figures for the trimers do not reflect the n values on the X-axis due to the software, which does not recalculate the molar ratio on the figure but does reflect the change in the fit obtained (MicroCal LLC, Northampton, MA).
Immunoelectron microscopy EM analysis of HIV Env derived from subtype C in different conformations such as trimer, dimer, and monomer was performed by negative staining as previously described (Srivastava et al., 2003) . The trimeric (pool 3; Fig. 4A ), dimeric (pool 4; Fig. 4A ), and monomeric (pool 5; Fig. 4A ) proteins obtained after the final preparative sizing column were diluted in borate-buffered saline, affixed to carbon membranes, stained with 1% uranyl formate, and mounted on copper grids for analysis. Electron micrographs were recorded at a nominal magnification of 100,000× at 100 kV on a JEOL JEM 1200EX electron microscope. Measurements were made using image analysis software Image-Pro Plus (http://www.mediacy.com/). Fifty or more particles from fractions corresponding to the putative monomer/dimer and trimer of gp140ΔV2 TV1 were measured and analyzed statistically.
